Annals of the American Thoracic Society

Journal

Publication Venue For

  • A Formative Evaluation of Patient and Family Caregiver Perspectives on Early Palliative Care in COPD across Disease Severity. 2019
  • Physical function trajectories in survivors of acute respiratory failure.  16:471-477. 2019
  • Safety and tolerability of comprehensive research bronchoscopy in chronic obstructive pulmonary disease results from the SPIROMICS bronchoscopy substudy.  16:439-446. 2019
  • Combined FEV1 and FVC Bronchodilator Response, Exacerbations, and Mortality in COPD. 2019
  • The Peak Index: Spirometry Metric for Airflow Obstruction Severity and Heterogeneity. 2019
  • Alignment of inhaled chronic obstructive pulmonary disease therapies with published strategies :analysis of the Global Initiative for Chronic Obstructive Lung Disease recommendations in SpiroMics.  16:200-208. 2019
  • Reducing chronic obstructive pulmonary disease hospital readmissions: An official American Thoracic Society workshop report.  16:161-170. 2019
  • Acquired cystic fibrosis transmembrane conductance regulator dysfunction and radiographic bronchiectasis in current and former smokers: A cross-sectional study.  16:150-153. 2019
  • It’s time to rehabilitate pulmonary rehabilitation.  16:55-57. 2019
  • Occupational exposures and computed tomographic imaging characteristics in the SpiromICS cohort.  15:1411-1419. 2018
  • Functional anatomic imaging of the airway surface.  15:S177-S183. 2018
  • Risk factors for and prediction of hypoxemia during tracheal intubation of Critically Ill Adults.  15:1320-1327. 2018
  • Searching for the source of the leak: PIE and the macklin effect.  15:1354-1356. 2018
  • Rural residence and chronic obstructive pulmonary disease exacerbations: Analysis of the SPIROMICS cohort.  15:808-815. 2018
  • Anemia and Adverse Outcomes in a Chronic Obstructive Pulmonary Disease Population with a High Burden of Comorbidities. An Analysis from SPIROMICS..  15:710-717. 2018
  • B-blocker therapy and clinical outcomes in patients with moderate chronic obstructive pulmonary disease and heightened cardiovascular risk an observational substudy of SUMMIT.  15:608-614. 2018
  • Home-based physical activity coaching, physical activity, and health care utilization in chronic obstructive pulmonary disease chronic obstructive pulmonary disease self-management activation research trial secondary outcomes.  15:470-478. 2018
  • Paratracheal paraseptal emphysema and expiratory central airway collapse in smokers.  15:479-484. 2018
  • Recent advances in computed tomography imaging in chronic obstructive pulmonary disease.  15:281-289. 2018
  • Diagnosis of chronic obstructive pulmonary disease: Breathing new life into an old debate.  15:163-165. 2018
  • Reply: We did this, and the patient improved: True, true, and unrelated?.  15:269. 2018
  • The "Obesity paradox" in chronic obstructive pulmonary disease: Can it be resolved?.  15:158-159. 2018
  • The long-term oxygen treatment trial for chronic obstructive pulmonary disease: Rationale, design, and lessons learned.  15:89-101. 2018
  • Handgrip strength in chronic obstructive pulmonary disease associations with acute exacerbations and body composition.  14:1638-1645. 2017
  • Mitochondrial dysfunction in pulmonary fibrosis.  14:S383-S388. 2017
  • Progressive dyspnea and back pain after complicated pneumonia.  14:1714-1717. 2017
  • Clinical risk factors and prognostic model for primary graft dysfunction after lung transplantation in patients with pulmonary hypertension.  14:1514-1522. 2017
  • Going with the flow: Saddle pulmonary embolism complicated by severe hypoxemia without shock.  14:1479-1484. 2017
  • Measures of frailty in chronic lung diseases.  14:1266-1267. 2017
  • An official American Thoracic Society Workshop Report: Chemical inhalational disasters biology of lung injury, development of novel therapeutics, and medical preparedness.  14:1060-1072. 2017
  • Respiratory symptoms items from the COPD assessment test identify ever-smokers with preserved lung function at higher risk for poor respiratory outcomes an analysis of the subpopulations and intermediate outcome measures in COPD Study cohort.  14:636-642. 2017
  • Results of a Medicare Bundled Payments for care Improvement initiative for chronic obstructive pulmonary disease readmissions.  14:643-648. 2017
  • Abnormal glucose metabolism and high-energy expenditure in idiopathic pulmonary arterial hypertension.  14:190-199. 2017
  • Characterization of prostacyclin-associated leg pain in patients with pulmonary arterial hypertension.  14:206-212. 2017
  • Lumacaftor/ivacaftor treatment of patients with cystic fibrosis heterozygous for F508del-CFTR.  14:213-219. 2017
  • Pulmonary rehabilitation improves outcomes in chronic obstructive pulmonary disease independent of disease burden.  14:26-32. 2017
  • Constrictive bronchiolitis in cystic fibrosis adolescents with refractory pulmonary decline.  13:2174-2183. 2016
  • Persistent and newly developed chronic bronchitis are associated with worse outcomes in chronic obstructive pulmonary disease.  13:1016-1025. 2016
  • A lifestyle physical activity intervention for patients with chronic obstructive pulmonary disease a randomized controlled trial.  13:617-626. 2016
  • Vitamin D concentrations and obstructive sleep apnea in a multicenter cohort of older males.  13:712-718. 2016
  • Neutrophil fates in bronchiectasis and alpha-1 antitrypsin deficiency.  13:S123-S129. 2016
  • Therapeutic approaches to acquired cystic fibrosis transmembrane conductance regulator dysfunction in Chronic bronchitis.  13:S169-S176. 2016
  • Depression is associated with readmission for acute exacerbation of chronic obstructive pulmonary disease.  13:197-203. 2016
  • Increased costs of the asthma-chronic obstructive pulmonary disease overlap syndrome one syndrome for the price of two?.  13:158-159. 2016
  • Attenuation of MIR-17∼92 cluster in bronchopulmonary dysplasia.  12:1506-1513. 2015
  • Spontaneous hemothorax resulting from tissue plasminogen activator in a patient with ischemic stroke and unrecognized recent myocardial infarction.  12:1105-1106. 2015
  • Pneumonia risk with inhaled fluticasone furoate and vilanterol compared with vilanterol alone in patients with COPD.  12:27-34. 2015
  • Reduced bone density and vertebral fractures in smokers. Men and COPD patients at increased risk.  12:648-656. 2015
  • The feasibility of lung transplantation in HIV-seropositive patients.  11:945-950. 2014
  • Characteristics of patients with pulmonary venoocclusive disease awaiting transplantation.  11:1411-1418. 2014
  • Domain-specific self-efficacy is associated with measures of functional capacity and quality of life among patients with moderate to severe chronic obstructive pulmonary disease.  11:310-315. 2014
  • FEV1/FEV6to diagnose airflow obstruction: Comparisons with computed tomography and morbidity indices.  11:335-341. 2014
  • Pneumothorax risk factors in smokers with and without chronic obstructive pulmonary disease.  11:1387-1394. 2014
  • Quantitative computed tomography measures of pectoralis muscle area and disease severity in chronic obstructive pulmonary disease: A cross-sectional study.  11:326-334. 2014
  • International Standard Serial Number (issn)

  • 2325-6621
  • Electronic International Standard Serial Number (eissn)

  • 2325-6621